More info
Novel highly effective and orally active P-gp inhibitor, effectively reversing multidrug resistance (MDR) to paclitaxel and colchicine in SW620/AD300 and HEK293T-ABCB1 cells, stimulating the P-gp ATPase activity and having moderate inhibition against CYP3A4